Privium Fund Management B.V.
Privium Fund Management B.V. reported 61 holdings worth US$544M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 7, 2026
Privium Fund Management B.V. reported 61 holdings worth US$544M as of Jun 30, 2026. Largest: Tesla, Inc., Shopify Inc. and Advanced Micro Devices Inc. Filed Aug 7, 2026 (Form 13F).
- Holdings
- 61
- Value as reported
- US$544M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Tesla, Inc. | 228K | US$95.9M | 17.6% |
| Shopify Inc. | 370K | US$42.2M | 7.8% |
| Advanced Micro Devices Inc | 62,000 | US$36M | 6.6% |
| Amazon.com, Inc. | 140K | US$33.4M | 6.1% |
| Ionis Pharmaceuticals, Inc. | 320K | US$25.4M | 4.7% |
| Palantir Technologies Inc. | 200K | US$23.3M | 4.3% |
| Arrowhead Pharmaceuticals, Inc. | 234K | US$19.1M | 3.5% |
| Opendoor Technologies Inc | 3.94M | US$18.2M | 3.3% |
| Lemonade, Inc. | 270K | US$17.6M | 3.2% |
| Nvidia Corporation | 81,000 | US$16.2M | 3.0% |
| Cerebras Systems Inc. | 60,500 | US$13.4M | 2.5% |
| Ast Spacemobile, Inc. | 145K | US$12.9M | 2.4% |
| Ultragenyx Pharmaceutical Inc. | 339K | US$11.3M | 2.1% |
| Arcutis Biotherapeutics, Inc. | 399K | US$10.5M | 1.9% |
| Biogen Inc. | 48,400 | US$10.5M | 1.9% |
| Axsome Therapeutics, Inc. | 39,944 | US$9.78M | 1.8% |
| Space Exploration Technologies Corp | 40,000 | US$6.83M | 1.3% |
| Denali Therapeutics Inc. | 230K | US$5.91M | 1.1% |
| Vertex Pharmaceuticals Incorporated | 9,400 | US$4.67M | 0.86% |
| Biomarin Pharmaceutical Inc. | 75,000 | US$4.29M | 0.79% |
| Krystal Biotech, Inc. | 11,170 | US$4.15M | 0.76% |
| Alnylam Pharmaceuticals, Inc. | 11,372 | US$3.42M | 0.63% |
| Viridian Therapeutics, Inc. | 174K | US$3.19M | 0.59% |
| Hims & Hers Health, Inc. | 80,000 | US$2.77M | 0.51% |
| Meiragtx Holdings Plc | 196K | US$2.65M | 0.49% |
| Ambev Sa | 802K | US$2.52M | 0.46% |
| Sarepta Therapeutics, Inc. | 137K | US$2.45M | 0.45% |
| Beam Therapeutics Inc. | 70,282 | US$2.41M | 0.44% |
| Zai Lab Ltd. | 122K | US$2.32M | 0.43% |
| Moderna, Inc. | 29,994 | US$2.1M | 0.39% |
| Cartesian Therapeutics, Inc. | 152K | US$1.58M | 0.29% |
| Taysha Gene Therapies, Inc. | 199K | US$1.35M | 0.25% |
| Zoetis Inc. | 17,322 | US$1.24M | 0.23% |
| 4d Molecular Therapeutics, Inc. | 90,110 | US$1.2M | 0.22% |
| Fate Therapeutics, Inc. | 414K | US$1.12M | 0.21% |
| Rocket Pharmaceuticals, Inc. | 244K | US$835K | 0.15% |
| Nov Inc. | 42,026 | US$780K | 0.14% |
| B2gold Corp. | 195K | US$730K | 0.13% |
| Lexeo Therapeutics, Inc. | 155K | US$722K | 0.13% |
| Molina Healthcare Inc | 2,979 | US$681K | 0.13% |
| Nu Holdings Ltd. | 44,000 | US$588K | 0.11% |
| Tidewater Inc. | 8,683 | US$579K | 0.11% |
| Lululemon Athletica Inc. | 5,063 | US$578K | 0.11% |
| Sandridge Energy, Inc. | 38,792 | US$531K | 0.10% |
| Voyager Therapeutics, Inc. | 120K | US$420K | 0.08% |
| Cosan S.a. | 52,000 | US$150K | 0.03% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Stoke Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Coinbase Global, Inc. | 0 | US$0 | 0.00% |
| Pfizer, Inc. | 0 | US$0 | 0.00% |
| Seabridge Gold Inc | 0 | US$0 | 0.00% |
| Pan American Silver Corp. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related